Edited by
S.J. Enna, Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, USA
J. August, John Hopkins University; Department of Pharmacology, Baltimore, Maryland, U.S.A.
Ferid Murad, University of Texas Medical School, Houston, U.S.A.
Description
A great deal of progress has been made in defining GABA (gamma-aminobutyric acid) transmission in the brain. Volume 54 of the Advances
in Pharmacology series has also provided new insights into fundamental features of neurotransmission in general, such as the importance
of allosterism and coincident signaling in regulating receptor function and overall cellular activity. These studies have led to the
design and development of new drugs and potential therapeutic agents.
Given the successes achieved over the first 50 years of GABA
research, it is certain the 6th decade will yield its share of surprising discoveries and new insights. Published in this volume are
articles providing thoughts and perspectives on this topic, some with the benefit of hindsight, others in the context of recent findings,
but all with a hint, or prediction, of what the future holds as the secrets of GABA neurotransmission continue to unfold.
Advances in Pharmacology is available online on ScienceDirect — full-text online of volumes 48
onwards.
Included in series
Advances in Pharmacology
Audience:
Academics and researchers in neuroscience, genetics, pharmacology, biology, neurology, and physiology.
